Tenderwize
Wróć do wyszukiwania

Open House Originale Agreement for Isavuconazole

Techniker Krankenkasse·Hamburg, Germany·Deadline Oct 30, 2027 · 431 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-29 - Isavuconazol

62/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

62 / 100

Złożoność

56 / 100

Czynniki ryzyka

The notice states that offers/contracts cannot be submitted via the portal; submission must be by email with qualified...

Eligibility is limited to pharmaceutical undertakings for the relevant product with valid authorization and no exclusio...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Supply-side open-house rebate agreement for Isavuconazole.
  • Conclusion of rebate contracts under Section 130c(1) SGB V.
Pokaż pełne podsumowanie

Open-house supply arrangement by Techniker Krankenkasse for the pharmaceutical product Isavuconazole (CPV 33600000). The notice says all suitable pharmaceutical companies that meet the stated legal and self-declaration requirements may join during the contract period, with no exclusivity and no individual negotiation. Contract term is up to 24 months from 01.11.2025 to 31.10.2027, with possible automatic earlier end if patent/market exclusivity ends. No contract value is stated. Electronic submission via the tender portal is not allowed; contracts must be sent electronically by email with qualified electronic signature or by post. Procurement documents are available online, but no extracted document text beyond the notice was provided.

Ryzyka

The notice states that offers/contracts cannot be submitted via the portal; submission must be by email with qualified...

Eligibility is limited to pharmaceutical undertakings for the relevant product with valid authorization and no exclusio...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Participant must be a pharmaceutical company within the meaning of German medicinal products law for the relevant product.
  • Company seat must be in the scope of the AMG, another EU Member State, or another EEA state.
  • Valid marketing authorization for the relevant medicinal product and/or other right to place it on the market in own name.

Kryteria udzielenia

Lot 1

No explicit lot-specific award criteria provided; the notice indicates this is an open-house arrangement with uniform conditions.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open House Originale Agreement for Isavuconazole

Single lot for supply-side open-house rebate agreements for Isavuconazole with TK. Scope is nationwide in Germany. The lot information comes from structured notice data and the TED XML notice. No separate lot value is stated.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Oct 2025 - Oct 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No explicit lot-specific award criteria provided; the notice indicates this is an open-house arrangement with uniform conditions.

Termin

Deadline Oct 30, 2027

Szczegóły zamówienia

Data publikacji
22 Sep 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
622464-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3